Videos / Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis
In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).
This Product Explainer is supported by CSL Seqirus
Multiple Sclerosis vs Antibody Disease – What GPs Need to Know
Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs
Menopause and MHT: Maximising Benefits & Minimising Risks
Peripheral Arterial Disease
expert
Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon